ABN AMRO: Better bottom line, mixed underlying, strong capital, SBB €250m. Ahold Delhaize: 2Q25 profitability beat thanks to insurance results. Coca-Cola Europacific Partners PLC: Fizzing along nicely. Kinepolis: July 2025 box office in US/Canada and France down, on strong comps. Vonovia: Good results, 5.6% guidance increase. UCB: Evenity continues to surprise to the upside. Zabka: Another miss on Adj. Net Income in 2Q25
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Belgian food retail: Carrefour plans to open all its stores on Sundays. Coca-Cola Europacific Partners: On course for FTSE inclusion. CVC Capital Partners: Stronger for longer. Econocom: REBITA in line but EBIT, net profit and net debt miss materially. Euronext: Strong finish. KPN: New “Althio” tower company deal closed. Recticel: Recovery in the Belgian construction sector expected by 2027F. Umicore: In-line 2024 and 2025 EBITDA guide, dividend cut and rebased. Wereldhave: €167m...
Liquidity testing for CCEP's admission to the FTSE UK Index Series started with the transfer of the company's shares to the (Commercial Companies) category of the Official List on 15 November 2024. The company has now met the liquidity requirements for November and the seasonally quiet month of December with two more months of testing required before possible admission to the FTSE 100 index in March 2025. With December's liquidity test met, we expect that January and February should be a formali...
Liquidity testing for CCEP's admission to the FTSE UK Index Series started with the transfer of the company's shares to the (Commercial Companies) category of the Official List on 15 November. The company has met the liquidity requirements for November with three more months of testing required before possible admission to the FTSE 100 index in March 2025. Based on the company's third quarter IMS, we adjust our earnings forecasts and raise our 12-month target price to €81.00 from €76.22 (based o...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.